Funding for this research was provided by:
Fogarty International Center (R25 TW 009697-01A1)
National Center for Advancing Translational Sciences (TL1 TR002000)
Received: 5 December 2020
Accepted: 24 March 2021
First Online: 7 May 2021
Change Date: 8 May 2021
Change Type: Update
Change Details: Some minor format changes have been made with Conclusion section.
: The MundoComm project was approved by the Universidad de Ciencias Médicas (UCIMED) FWA Institutional Review Board in Costa Rica and (with local approval) in Honduras (as a proxy, since Honduras did not have an FWA Institutional Review Board). In addition, in the Dominican Republic, the study was reviewed and approved by Consejo Nacional de Bioética en Salud (CONABIOS) at the national level and the Pontificia Universidad Católica Madre y Maestra (PUCMM)‘s FWA Institutional Review Board at the university level. Regulatory language for each country agency was incorporated in the survey. Additionally, the project was approved by the University of Rochester’s Research Subjects Review Board. Study participants had to be able to read and verbally consent to participate. All personnel for this project completed CITI Program Training in Human Subjects Protection or the NIH’s <i>Protección de los participantes humanos de la investigación</i> training.
: The authors declare that they have no competing interests.